Heart Failure Patients Shouldn't Stop Meds Even if Condition Improves: Study

TUESDAY, Nov. 13, 2018 -- There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds. Any progress they've seen on medication is likely to fade once they stop taking their heart drugs, new clinical...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

We present a retrospective review of 13 consecutive children who underwent implantation of VAD between 2001 and 2018 in our center. The median age was 12  years (1–17 years), weight was 45 kg (10–82 kg). Etiologies of heart failure were dilated cardiomyopathy (CMP) (n = 8), myocarditis (n = 2), ischemic CMP (n = 1), restrictive CMP (n = 1) and congenital heart disease (n = 1). Pre-implantation ECMO was used in 5, mechanical ventilation in 4, renal replacement therapy in 2 and IABP in 1. Devices used were: Berlin Heart EXCO...
Source: Journal of Artificial Organs - Category: Transplant Surgery Source Type: research
ConclusionsWe describe a unique and novel cellular model that provides insight into the mitochondrial abnormalities present in DCMA and identifies SS-31 as a potential therapeutic for this devastating disease.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Nature Reviews Cardiology, Published online: 11 October 2019; doi:10.1038/s41569-019-0284-0In this Review, Rosenbaum and colleagues give a broad perspective on the genetic causes of dilated cardiomyopathy to provide a context for a discussion of the pragmatic use of genetic testing in heart failure clinics for patients presenting with new-onset dilated cardiomyopathy.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Source Type: research
Publication date: Available online 7 October 2019Source: Journal of Cardiology CasesAuthor(s): Genzou Takemura, Kenji Onoue, Takanori Arimoto, Tetsu Watanabe, Akiko Tsujimoto, Chihiro Takada, Hideshi Okada, Tomoya Nakano, Yasuhiro Sakaguchi, Nagisa Miyazaki, Takatomo Watanabe, Hiromitsu Kanamori, Shinji Ogura, Yoshihiko Saito, Takako Fujiwara, Hisayoshi Fujiwara, Yasuaki HottaAbstractWe encountered an unfamiliar finding during electron microscopic examination of an endomyocardial biopsy obtained from a 55-year-old woman suffering from heart failure due to dilated phase hypertrophic cardiomyopathy. Many cardiomyocytes conta...
Source: Journal of Cardiology Cases - Category: Cardiology Source Type: research
In conclusion, AF seems to have a higher prevalence in the general population than previously thought, and is mostly associa ted with hypertension, cardiomyopathy and rheumatic heart disease in SSA. It is associated with a high incidence of heart failure and stroke. The management of AF is suboptimal in SSA, especially with a low uptake of oral anticoagulation.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Tags: COMPREHENSIVE REVIEWS Source Type: research
Conclusions: We report the identification of a novel mutation in RBM20 by WES in a large pedigree with DCM. PMID: 31583969 [PubMed - as supplied by publisher]
Source: Acta Cardiologica - Category: Cardiology Tags: Acta Cardiol Source Type: research
We present a 26-year-old woman with an inotrope dependent severe dilated cardiomyopathy potentially caused by chronic ingestion of ED. The extensive investigation, consisting of cardiac magnetic resonance, F-18-fluorodesoxyglucose-positron emission tomography, coronary angiography and endomyocardial biopsy, was normal. A left ventricular assist device (LVAD) was implanted as a potential bridge to recovery. After 10 months of mechanical support and pharmacological treatment, cardiac function was recovered, and the LVAD was successfully explanted. This is the first case report of ED abuse leading to severe heart failure requ...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Conclusions: The canine model of CCC mimics human disease, reproducing the percentage of individuals that develop heart failure during the chronic infection. It is thus mandatory to establish inclusion criteria in the experimental design of canine preclinical studies to account for the variable effect that chronic infection has on systolic function.
Source: Frontiers in cellular and infection microbiology - Category: Microbiology Source Type: research
This study investigated whether targeted blood and urine metabolomics reflects disease severity in non-ischemic dilated cardiomyopathy (DCM) patients and compared its incremental value on top of NT-proBNP.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Tags: Original article Source Type: research
This study investigated whether targeted blood and urine metabolomics reflects disease severity in patients with nonischemic dilated cardiomyopathy (DCM) and compared its incremental value on top of N-terminal prohormone of brain natriuretic peptide (NT-proBNP).
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Source Type: research
More News: Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | General Medicine | Heart | Heart Failure | Study